Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant Pfs25.
Kaslow
D C
DC
National Institute of Allergy and Infectious Diseases, Malaria Section, National Institutes of Health, Bethesda, MD 20892.
Bathurst
I C
IC
Isaacs
S N
SN
Keister
D B
DB
Moss
B
B
Barr
P J
PJ
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000913:Antibodies, Protozoan / Q000276:immunology*; D000953:Antigens, Protozoan / Q000276:immunology*; D000882:Haplorhini / Q000276:immunology; D017780:Malaria Vaccines / Q000276:immunology; D051379:Mice; D010963:Plasmodium falciparum / Q000276:immunology*; D015800:Protozoan Proteins / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000276:immunology; D014611:Vaccination
D000911:Antibodies, Monoclonal; D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D017780:Malaria Vaccines; C071284:Pfs25 protein, Plasmodium falciparum; D015800:Protozoan Proteins; D011993:Recombinant Fusion Proteins